TY  - GEN
AU  - Moore,Malcolm J
AU  - Goldstein,David
AU  - Hamm,John
AU  - Figer,Arie
AU  - Hecht,Joel R
AU  - Gallinger,Steven
AU  - Au,Heather J
AU  - Murawa,Pawel
AU  - Walde,David
AU  - Wolff,Robert A
AU  - Campos,Daniel
AU  - Lim,Robert
AU  - Ding,Keyue
AU  - Clark,Gary
AU  - Voskoglou-Nomikos,Theodora
AU  - Ptasynski,Mieke
AU  - Parulekar,Wendy
TI  - Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group
SN  - 1527-7755
PY  - 2007///0608
KW  - Adenocarcinoma
KW  - drug therapy
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Deoxycytidine
KW  - administration & dosage
KW  - Double-Blind Method
KW  - Erlotinib Hydrochloride
KW  - Female
KW  - Humans
KW  - International Agencies
KW  - Male
KW  - Middle Aged
KW  - Pancreatic Neoplasms
KW  - Placebos
KW  - Prognosis
KW  - Quinazolines
KW  - Survival Rate
KW  - Treatment Outcome
KW  - Gemcitabine
N1  - Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1200/JCO.2006.07.9525
ER  -